Nova Eye Medical Statistics

Total Valuation

ASX:EYE has a market cap or net worth of AUD 41.30 million. The enterprise value is 41.47 million.

Market Cap	41.30M
Enterprise Value	41.47M

Important Dates

The next estimated earnings date is Tuesday, May 26, 2026.

Earnings Date	May 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:EYE has 284.82 million shares outstanding. The number of shares has increased by 23.07% in one year.

Current Share Class	284.82M
Shares Outstanding	284.82M
Shares Change (YoY)	+23.07%
Shares Change (QoQ)	+15.51%
Owned by Insiders (%)	6.75%
Owned by Institutions (%)	17.46%
Float	233.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.25
PB Ratio	2.61
P/TBV Ratio	4.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.90
EV / Sales	1.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.96

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.18.

Current Ratio	1.85
Quick Ratio	1.18
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-0.54
Interest Coverage	-38.45

Financial Efficiency

Return on equity (ROE) is -42.35% and return on invested capital (ROIC) is -44.23%.

Return on Equity (ROE)	-42.35%
Return on Assets (ROA)	-17.92%
Return on Invested Capital (ROIC)	-44.23%
Return on Capital Employed (ROCE)	-39.37%
Weighted Average Cost of Capital (WACC)	8.50%
Revenue Per Employee	109,814
Profits Per Employee	-23,355
Employee Count	301
Asset Turnover	1.34
Inventory Turnover	2.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.10% in the last 52 weeks. The beta is 0.81, so ASX:EYE's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	+38.10%
50-Day Moving Average	0.16
200-Day Moving Average	0.14
Relative Strength Index (RSI)	37.73
Average Volume (20 Days)	288,292

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:EYE had revenue of AUD 33.05 million and -7.03 million in losses. Loss per share was -0.03.

Revenue	33.05M
Gross Profit	22.05M
Operating Income	-7.07M
Pretax Income	-7.03M
Net Income	-7.03M
EBITDA	-4.88M
EBIT	-7.07M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 2.62 million in cash and 2.79 million in debt, giving a net cash position of -170,000 or -0.00 per share.

Cash & Cash Equivalents	2.62M
Total Debt	2.79M
Net Cash	-170,000
Net Cash Per Share	-0.00
Equity (Book Value)	15.82M
Book Value Per Share	0.06
Working Capital	4.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.87 million and capital expenditures -342,000, giving a free cash flow of -5.21 million.

Operating Cash Flow	-4.87M
Capital Expenditures	-342,000
Free Cash Flow	-5.21M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 66.71%, with operating and profit margins of -21.40% and -21.27%.

Gross Margin	66.71%
Operating Margin	-21.40%
Pretax Margin	-21.27%
Profit Margin	-21.27%
EBITDA Margin	-14.77%
EBIT Margin	-21.40%
FCF Margin	n/a

Dividends & Yields

ASX:EYE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.07%
Shareholder Yield	-23.07%
Earnings Yield	-17.02%
FCF Yield	-12.62%

Dividend Details

Stock Splits

The last stock split was on July 10, 2001. It was a reverse split with a ratio of 0.2.

Last Split Date	Jul 10, 2001
Split Type	Reverse
Split Ratio	0.2

Scores

ASX:EYE has an Altman Z-Score of 0.92 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.92
Piotroski F-Score	3